BBL Scars After One Year: What They Really Look Like in 2026

By the twelve-month mark, a Brazilian Butt Lift patient has lived through the dramatic phase of healing — the swelling, the compression garments, the no-sitting rules — and is left with what the scars are actually going to be. This is the honest assessment phase. Marketing photos taken at week six show fresh pink lines that look temporary. The reality at month twelve is different: scars have largely matured, color has settled, and what is visible now is close to what will be visible at year five. This article covers what BBL scars look like at one year, why some fade and others do not, how skin tone changes the outcome, and which interventions still help after the twelve-month maturation window.

Quick overview

A BBL produces two distinct categories of scarring: small injection-site scars on the buttocks where fat was deposited, and liposuction donor-site scars on the abdomen, flanks, lower back, or thighs where fat was harvested. The injection scars are typically 3–4 mm and tend to fade to near-imperceptible by twelve months [2]. The donor-site scars are the ones patients actually see in the mirror at one year — and they range from invisible to clearly pigmented depending on skin type, closure technique, and aftercare.

Peer-reviewed data from Plastic and Reconstructive Surgery indicates scar maturation extends 12–18 months post-BBL, with roughly 60–70% improvement in scar appearance from the early post-op baseline by the one-year mark [1]. The American Society of Plastic Surgeons reports that 85% of BBL patients describe their scarring as acceptable by twelve months [5]. That leaves a meaningful minority — roughly one in seven — for whom scars at year one are not what was expected. Understanding which group a patient falls into requires looking at biology, not marketing copy.

What BBL scars actually look like at twelve months

At one year post-op, a typical BBL scar profile looks like this:

Injection scars on the buttocks. Surgeons use 3–4 mm cannula entry points to inject fat. These are usually placed in the intergluteal crease, lateral hip, or lower buttock fold. By twelve months, the majority have faded to small pale or skin-toned dots, often visible only at close range under direct light [2]. In patients with lighter Fitzpatrick skin types (I–III), they may be nearly invisible. In darker skin types (IV–VI), residual hyperpigmentation is more common and the marks may remain darker than surrounding skin [2].

Liposuction donor-site scars. These are the more visible scars. They sit at the entry points used to harvest fat — typically the lower abdomen, flanks, lower back, and inner or outer thighs. Each measures 3–5 mm in length [3]. At twelve months, the scar is generally flat, soft, and pale, but width and pigmentation vary. Aesthetic Surgery Journal data shows donor-site liposuction scars remain visible in 20–30% of patients at one year without scar-focused intervention [2].

Color. Fresh scars are pink to red because of vascularization. By month twelve, most have transitioned to white, light pink, or — in darker skin types — a darker brown or purple pigment from post-inflammatory hyperpigmentation [2]. The color seen at twelve months is generally within 10–15% of the final color seen at eighteen months.

Texture. Most one-year scars are flat. The 5–15% of patients who develop hypertrophic scarring will see raised, firm, sometimes itchy scar tissue confined to the original incision line [1]. Keloid formation — scarring that extends beyond the original wound — occurs in 1–3% of BBL cases, with higher rates in Fitzpatrick types IV–VI [4].

Why scars look different at one year than patients expect

There is a recurring gap between the "scars fade to nothing" messaging that patients absorb during consultations and what they see in the mirror at month twelve. The biology is straightforward.

Closure technique matters more than incision size

A 4 mm incision closed under tension scars worse than a 6 mm incision closed without tension. Comparative data in Aesthetic Surgery Journal shows that intradermal suture closure produces narrower scars at twelve months than simple interrupted closure, and that tension-free closure reduces hypertrophic scar risk by approximately 40% [6]. Surgeons who rush closure or who over-aspirate the donor site (leaving tight, retracted skin) produce worse scars regardless of how small the incision was.

Placement determines visibility

Incisions placed inside natural skin creases — the intergluteal crease, the inguinal fold, the lower abdominal crease — show roughly 50% better camouflage at twelve months than incisions placed on flat skin [6]. Patients evaluating before-and-after photos at one year should specifically ask where each incision was placed, not just count them.

Skin tone changes the equation

Darker skin types are more reactive. Post-inflammatory hyperpigmentation is more common, keloid risk is higher, and the contrast between scar and surrounding skin can persist longer [2][4]. This is not a reason to avoid BBL; it is a reason to have a frank conversation about scar management protocols specific to Fitzpatrick IV–VI skin during the consultation, not after the fact.

Aftercare compliance

Early scar management — silicone gel sheets or gel applied from weeks two through twelve, daily sun protection on any visible donor sites, and pressure garments worn through the recommended period — reduces final scar appearance by 20–35% [7]. Patients who skip these steps generally see the result at twelve months.

Scar appearance by donor site

Not all donor-site scars heal equally. Location influences both visibility and how the scar behaves long-term.

Abdomen and lower flanks. These are the most common donor sites. Scars placed near the bikini line or umbilicus tend to be well-camouflaged by twelve months. Scars on the upper flanks or around the bra line are more visible in everyday clothing.

Lower back. Often used for the "shelf" contouring that defines a BBL silhouette. Scars here are usually small and well-positioned, but the skin tension across the lower back can produce wider scars in patients with significant skin laxity.

Inner and outer thighs. Thigh skin is thinner and more mobile. Scars in this region heal well in most patients but are more prone to widening over time, particularly on the inner thigh where skin friction is constant.

Arms and upper back (less common). When the surgeon harvests fat from secondary sites to reach desired volume, those scars follow standard liposuction healing patterns and are generally inconspicuous by twelve months [1].

Donor-site selection is part of the surgical plan, and patients reviewing BBL options in cities like Miami or Los Angeles should ask each surgeon specifically where they plan to harvest and why.

Real patient results

From verified board-certified surgeons in our directory.

Dr. Pauline Joy Santos

Orange, CA

View →

Dr. Pauline Joy Santos

Orange, CA

View →

Dr. Alfredo Lloreda

Latham, NY

View →

Dr. Alfredo Lloreda

Latham, NY

View →

What to do if scars haven't faded by twelve months

The twelve-month mark is the appropriate time to evaluate residual scarring and consider intervention. Treatments performed earlier are working against active remodeling; treatments performed after twelve months work with mature tissue and produce more predictable results [4].

Fractional laser resurfacing

Fractional CO2 laser is the workhorse for residual BBL scars at twelve months and beyond. Published data shows 40–60% improvement in residual scar appearance in patients treated after the twelve-month maturation window [4]. Multiple sessions are typical — usually two to four, spaced six to eight weeks apart. Laser is more effective for texture (width, surface irregularity) than for pigment, and carries elevated hyperpigmentation risk in darker skin types, requiring careful settings and pre-treatment skin priming.

Microneedling

Microneedling started at six months and continued through twelve months improves scar texture in 55–70% of cases [7]. It is less aggressive than laser, has minimal downtime, and is generally safer across all skin types. It is the preferred starting point for patients with Fitzpatrick IV–VI skin who want texture improvement without significant pigmentation risk.

Intralesional steroid injections

For hypertrophic or keloid scars at twelve months, triamcinolone injections every four to six weeks are standard. They flatten raised scar tissue and reduce itching, though they do not address pigmentation. Three to six sessions are typical for a clear response.

Topical silicone

Silicone gel or sheeting continued into months 12–18 still produces measurable benefit — published data shows 15–25% reduction in scar width when used consistently across the early maturation window [3]. It is inexpensive, low-risk, and worth continuing even if other treatments are layered on top.

Surgical scar revision

For a small number of patients with widened, depressed, or hypertrophic donor-site scars that do not respond to non-surgical treatment, surgical revision after the twelve-month mark can re-excise and re-close the scar under better tension. This is most useful for visible flank or thigh scars and is typically performed under local anesthesia.

How to choose a surgeon when scarring matters to you

Scar outcomes are partly biology and partly technique. The technique half is controlled by the surgeon. When evaluating BBL surgeons, the questions that distinguish good outcomes from bad ones at twelve months are practical:

• Where will incisions be placed, and which will be inside natural creases?
• What closure technique is used — intradermal sutures, or simple interrupted?
• What is the surgeon's documented hypertrophic scar and keloid rate in skin types similar to the patient's?
• What scar management protocol does the practice provide, and through what timeframe?
• Can the surgeon show one-year photos (not six-week photos) of donor sites in patients with similar skin tone?

Board certification by the American Board of Plastic Surgery is the baseline credential. Beyond that, the willingness to show twelve-month photos — not curated early-recovery shots — is the most useful filter. Surgeons performing high volumes in New York, Houston, and Atlanta should be able to produce these without hesitation.

Cost of scar treatment after BBL

Residual scar treatment after the twelve-month mark is generally not included in the original BBL price. Patients budgeting realistically should be aware of typical add-on costs if scars do not fade adequately. The base BBL price varies significantly by market — a full breakdown is available in the complete BBL cost guide and on the cost-of-BBL page.

Fractional laser sessions, microneedling packages, and steroid injection series each add several hundred to a few thousand dollars depending on geography and the number of sessions required. Surgical scar revision performed under local anesthesia is typically a four-figure procedure. None of this is catastrophic, but it should be part of the financial planning conversation, not a surprise at month thirteen.

Realistic expectations vs. marketing claims

The phrase "BBL scars are invisible" is marketing, not medicine. The accurate phrasing — supported by the literature — is that BBL injection scars become near-imperceptible in most patients by twelve months, and donor-site scars become well-tolerated in roughly 85% of patients by twelve months [2][5]. The remaining 15% have visible, sometimes problematic scarring that benefits from active intervention.

A reasonable expectation at one year is: small, flat, pale lines at the donor sites that are visible under direct inspection but not from a normal social distance; barely visible dots at the injection sites; and a finished color that will not change dramatically going forward. A patient still seeing red, raised, itchy, or widening scars at twelve months has a treatable problem, not a permanent one — but it requires action rather than further waiting.

The honest verdict

BBL scars at one year are real, visible to the patient, and almost always acceptable when surgical technique, skin type, and aftercare align. They are largely mature by twelve months, with refinement continuing through month eighteen. The patients most likely to be unhappy at year one are those who were told scarring would be "invisible," those whose surgeons placed incisions outside natural creases, and those who skipped silicone, sun protection, and follow-up. The patients most likely to be satisfied are those who treated scar management as a year-long protocol rather than a six-week errand.

For patients still inside the recovery window, the week-by-week sitting guide and recovery wardrobe guide cover the practical mechanics of healing that directly influence scar quality at year one. For patients deciding between procedures, the BBL vs. fat transfer comparison and fat survival timeline provide the broader context.

This article is for educational purposes only and does not constitute medical advice. Individual outcomes vary. Patients considering a BBL or scar revision should consult a board-certified plastic surgeon for personalized evaluation.